Samira Sakhia Insider Profile
4 Followers
Samira Sakhia, President & Chief Executive Officer at Knight Therapeutics, holds 451.03K shares in Knight Therapeutics (Ticker: KHTRF), holds 13.78K shares in Nuvo Pharmaceuticals (Ticker: ~TSE:MRV), holds 250.00K shares in Antibe Therapeutics (Ticker: ATBPF).
Samira Sakhia's Trading History
| KHTRFKnight Therapeutics | Sep 19, 2026 | President & Chief Executive Officer | Uninformative Buy | 18.98K | $3.50M | |
| MRVNuvo Pharmaceuticals | Mar 07, 2016 | ― | Uninformative Buy | ― | C$18.53K | |
| ATBPFAntibe Therapeutics | Apr 07, 2015 | ― | Informative Buy | 25.00K | $53.75K |
You May Also Like
Samira Sakhia insider profile FAQ
What is the percentage of profitable transactions made by Samira Sakhia?
The percentage of profitable transactions made by Samira Sakhia is 31%.
What is the average return per transaction made by Samira Sakhia?
The average return per transaction made by Samira Sakhia is -3.10%.
What stocks does Samira Sakhia hold?
Samira Sakhia holds: KHTRF, ~TSE:MRV, ATBPF stocks.
What was Samira Sakhia’s latest transaction?
Samira Sakhia’s latest transaction was an Uninformative Buy of $18.98K.
What was Samira Sakhia's most profitable transaction?
Samira Sakhia’s most profitable transaction was an Informative Buy of ~TSE:MRV stock on January 7, 2016. The return on the trade was 53.00%.
What is Samira Sakhia's role in Knight Therapeutics?
Samira Sakhia's role in Knight Therapeutics is President & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
